In the 2023 New England Journal of Medicine Phase 2 obesity trial, participants receiving the highest doses (12 mg weekly) achieved an average body weight reduction of approximately 24% over 48 weeks , alongside structured lifestyle support
GIP receptors exist in fat tissue, bone, and the brain
Addressing Collagen, Elastin, and Facial Fat Loss Together One of the most overlooked aspects of post-weight-loss facial aging is the combined loss of: Facial fat Collagen Elastin Sculptra addresses the biological loss of collagen by working gradually beneath the surface of the skin
GLP-1s are typically prescribed at a higher dose for obesity than for diabetes
Dammes N, Goldsmith M, Ramishetti S, Dearling J, Veiga N, Packard AB, Peer D